Who is responsible for managing tacrolimus dosing in a patient with a history of liver transplantation who is currently admitted for appendicitis?

Tacrolimus Management Responsibility in Hospitalized Liver Transplant Patients

The transplant center/transplant hepatology team maintains primary responsibility for managing tacrolimus dosing in liver transplant recipients, even when admitted to non-transplant services for unrelated conditions like appendicitis 1.

Primary Management Structure

The evidence is unequivocal that immunosuppression management remains under the purview of the transplant center regardless of admission reason 1. This is not a shared responsibility—the admitting surgical or medical team should consult the transplant service immediately upon admission.

Practical Implementation

• The admitting team (general surgery for appendicitis) should:

  • Contact the transplant hepatology service on admission
  • Continue the patient's home tacrolimus regimen without modification unless directed by transplant
  • Order tacrolimus trough levels as specified by transplant protocols
  • Never adjust doses independently due to the narrow therapeutic window 1

• The transplant team will:

  • Review all tacrolimus levels and make dosing adjustments
  • Monitor for drug interactions with new medications (antibiotics, analgesics)
  • Adjust for clinical factors affecting absorption (NPO status, diarrhea, surgical stress)

Critical Considerations During Acute Illness

Drug Interactions

Antibiotics commonly used for appendicitis can significantly alter tacrolimus levels 1:

• Rifampin/rifabutin decrease levels (may precipitate rejection)
• Many other antibiotics can increase or decrease tacrolimus metabolism
• The transplant team must review all new medications before administration

Target Trough Levels

For a stable, long-term liver transplant recipient (beyond 1 year post-transplant), target tacrolimus levels are typically 4-6 ng/mL for monotherapy or 3-5 ng/mL if combined with other immunosuppressants 2. However, the specific target for this individual patient must come from their transplant center.

Absorption Issues

During acute surgical illness:

• NPO status: Coordinate with transplant team—may need IV tacrolimus or dose adjustment when oral intake resumes
• Postoperative ileus: Can affect absorption unpredictably
• Inflammatory states: May alter drug metabolism 3

Common Pitfalls to Avoid

1. Never assume standard dosing applies: Tacrolimus dosing is highly individualized based on CYP3A5 genotype, time from transplant, rejection history, and renal function 1, 4

2. Don't delay transplant consultation: Even a 24-hour delay in appropriate level monitoring or dose adjustment can risk rejection or toxicity 1

3. Avoid generic substitutions without transplant approval: Switching formulations can cause significant level fluctuations 1

4. Don't hold tacrolimus for surgery: Unless specifically directed by transplant team, continue immunosuppression perioperatively

Laboratory Monitoring

The transplant team will specify monitoring frequency, but typically:

• Trough levels should be drawn immediately before the morning dose
• Daily levels during acute illness until stable
• Renal function, liver enzymes, and electrolytes (tacrolimus causes nephrotoxicity and hyperkalemia) 1

The admitting team can order these labs at the transplant team's direction, but interpretation and dose adjustment remain with the transplant service 1.